candesartan cilexetil has been researched along with Dizzyness in 1 studies
candesartan cilexetil: a prodrug which is metabolized to an active form candesartan to exert its biological effects
| Excerpt | Relevance | Reference |
|---|---|---|
| "In Korean adult patients with stage II hypertension, we evaluated the efficacy and tolerability of candesartan 16 mg/hydrochlorothiazide (HCT) 12." | 9.15 | Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension. ( Ahn, YK; Choi, D; Chung, WJ; Hong, BK; Jeon, DW; Jung, HO; Kim, BO; Kim, D; Kim, SH; Lee, BK; Lee, HY; Lee, SH; Park, CK, 2011) |
| "In Korean adult patients with stage II hypertension, we evaluated the efficacy and tolerability of candesartan 16 mg/hydrochlorothiazide (HCT) 12." | 5.15 | Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension. ( Ahn, YK; Choi, D; Chung, WJ; Hong, BK; Jeon, DW; Jung, HO; Kim, BO; Kim, D; Kim, SH; Lee, BK; Lee, HY; Lee, SH; Park, CK, 2011) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Lee, HY | 1 |
| Hong, BK | 1 |
| Chung, WJ | 1 |
| Lee, BK | 1 |
| Lee, SH | 1 |
| Jeon, DW | 1 |
| Ahn, YK | 1 |
| Kim, D | 1 |
| Park, CK | 1 |
| Kim, SH | 1 |
| Jung, HO | 1 |
| Kim, BO | 1 |
| Choi, D | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Open-label, Randomised, 2-Arm Parallel Group, Multicentre, 8-week, Phase IV Study to Assess the Antihypertensive Efficacy and Safety of the Candesartan Cilexetil 16 mg and Hydrochlorothiazide 12.5 mg Combination Therapy in Comparison With Candesartan 16 m[NCT00621153] | Phase 4 | 214 participants (Actual) | Interventional | 2008-02-29 | Completed | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
Mean of the changed DBP from baseline after 4 weeks (NCT00621153)
Timeframe: 4 weeks
| Intervention | mmHg (Least Squares Mean) |
|---|---|
| Candesartan Cilexetil/Hydroclorozide Combination Therapy | -17.0 |
| Candesartan Cilexetil Monotherapy | -14.1 |
1 trial available for candesartan cilexetil and Dizzyness
| Article | Year |
|---|---|
Phase IV, 8-week, multicenter, randomized, active treatment-controlled, parallel group, efficacy, and tolerability study of high-dose candesartan cilexetil combined with hydrochlorothiazide in Korean adults with stage II hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Asian People; Benzimidazoles; Biphenyl Compounds; Blood Pressu | 2011 |